Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: A review of the PICNIC RSV database

Pediatric Infectious Disease Journal

Volumn 18, Issue 10, 1999, Pages 866-869

  Arnold, Sandra R ^a   Wang, Elaine E L ^a,j   Law, Barbara J ^b   Boucher, François D ^c   Stephens, Derek ^a   Robinson, Joan L ^d   Dobson, Simon ^e   Langley, Joanne M ^f   Mcdonald, Jane ^g   Macdonald, Noni E ^h   Mitchell, Ian ⁱ  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f DALHOUSIE UNIVERSITY   (Canada)

^g MONTREAL CHILDREN S HOSPITAL   (Canada)

^h CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j Clinical and Medical Affairs   (Canada)

more..

Author keywords

Aspiration pneumonia; Bronchopulmonary dysplasia; Bronchopulmonary malformation; Cystic fibrosis; Neuromuscular diseases; Respiratory syncytial virus; Tracheoesophageal fistula

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; DISEASE ASSOCIATION; HOSPITALIZATION; HUMAN; INFANT; LUNG DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; VIRUS INFECTION;

BRONCHOPULMONARY DYSPLASIA; CANADA; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; LUNG DISEASES; MORBIDITY; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; STATISTICS, NONPARAMETRIC;

EID: 0032829993     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199910000-00006     Document Type: Article

References (15)

1. MacDonald NE, Hall CB, Suffin SC, Alexson C, Harris PJ, Manning JA. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med 1982;307:397-400.
2. Meert K, Heidemann S, Lieh-Lai M, Sarnaik AP. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 1989;7:167-70.
3. Groothuis JR, Gutierrez KM, Lauer BA. Respiratory syncytial virus infection in children with bronchopulmonary dysplasia. Pediatrics 1988;82:199-203.
4. Stretton M, Ajizian SJ, Mitchell I, Newth CJL. Intensive care course and outcome of patients infected with respiratory syncytial virus. Pediatr Pulmonol 1992;13:143-50.
5. Wang EEL, Law BJ, Stephens D, and other members of PICNIC. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126:212-19.
6. Abman SH, Ogle JW, Butler-Simon N, Rumack CM, Accurso FJ. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr 1988;113:826-30.
7. McMillan JA, Tristram DA, Weiner LB, Higgins AP, Sandstrom C, Brandon R. Prediction of the duration of hospitalization in patients with respiratory syncytial virus infection: use of clinical parameters. Pediatrics 1988;81:22-6.
8. Groothuis JR, Simoes EAF, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. N Engl J Med 1993;329:1524-30.
9. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-9.
10. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
11. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Prevention of respiratory syncytial virus infections: indications for the use of Palivizumab and update on the use of RSV-IGIV. Pediatrics 1998;102:1211-16.
12. Navas L, Wang E, De Carvalho V, Robinson J, and the Pediatric Investigators Collaborative Network on Infections in Canada. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr 1992;121:348-54.
13. Wang EEL, Law BJ, Robinson JL, et al. PICNIC (Pediatric Investigators Collaborative Network on Infections in Canada) study of the role of age and respiratory syncytial virus neutralizing antibody on respiratory syncytial virus illness in patients with underlying heart or lung disease. Pediatrics 1997;99(3):e9.
14. Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-6.
15. Henderson FW, Collier AM, Clyde WA Jr, Denny FW. Respiratory-syncytial-virus infections, reinfections and immunity: a prospective, longitudinal study in young children. N Engl J Med 1979;300:530-4.